PUBLIC DISCLOSURE & CLARIFICATION
BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
banner
Composite Nanoparticles
Inquiry

Composite Nanoparticles

Inquiry
Cat. No. Product Name Inquiry
X26-06-ZQ3104 Carbon-coated silver core-shell nanoparticles (Ag@C)
X26-06-ZQ3105 Silver nanorod solutions (AgNR solutions)
X26-06-ZQ3106 Zinc oxide/multi-walled carbon nanotube composites (ZnO/MWCNTs)
X26-06-ZQ3107 Colloidal silver (Ag colloids)
X26-06-ZQ3108 Bismuth telluride/carbon nanotube composites (Bi2Te3/CNTs)
X26-06-ZQ3109 Silver nanoparticle-modified polymers
X26-06-ZQ3110 Polydopamine-coated silver nanoparticles (PDA@AgNPs)
X26-06-ZQ3111 Silver nanoparticle/titanium dioxide/chitosan ternary nanocomposites (Ag/TiO2/CS)
X26-06-ZQ3112 Silver nanoparticle nanocomposites (Ag nanocomposites)
X26-06-ZQ3113 Salicylic acid-modified silver nanoparticles
X26-06-ZQ3114 Methoxy-PEGylated silver nanoparticles (mPEG-AgNPs)
X26-06-ZQ3115 Amino-PEGylated silver nanoparticles (NH2-PEG-AgNPs)
X26-06-ZQ3116 Silver nanoparticle-decorated chitosan/cellulose nanofiber composites (Ag/CS-CNF)
X26-06-ZQ3117 Glucose oxidase-modified silver nanoparticles (GOD-AgNPs)
X26-06-ZQ3118 Graphene/chitosan/silver nanoparticle ternary nanocomposites (Gr/CS/Ag)
X26-06-ZQ3119 Silver nanoparticle-modified polyethersulfone (AgNPs/PES)
X26-06-ZQ3120 Protein G-functionalized silver nanoparticles (Protein G-AgNPs)
X26-06-ZQ3121 PEG-grafted chitosan-modified silver nanoparticles (PEG-g-CS/AgNPs)
X26-06-ZQ3122 Doxorubicin-functionalized silver nanoparticles (DOX-AgNPs)
X26-06-ZQ3123 Cyclodextrin-modified silver nanoparticles (CD-AgNPs)
X26-06-ZQ3124 1-Thiol-Lactose-functionalized silver nanoparticles (1-thiol-Lactose-AgNPs)
X26-06-ZQ3125 Silver nanoparticle-decorated microporous organic framework materials (Ag/MPOF)
X26-06-ZQ3126 Glucose-functionalized silver nanoparticles (Glucose-AgNPs)
X26-06-ZQ3127 Chitosan oligosaccharide-modified silver nanoparticles (CSO-AgNPs)
X26-06-ZQ3128 Carboxyl-PEGylated silver nanoparticles (COOH-PEG-AgNPs)
X26-06-ZQ3129 Chitosan oligosaccharide-grafted polyethylenimine copolymers (CSO-g-PEI)
X26-06-ZQ3130 Sodium citrate-stabilized silver nanoparticles (Citrate-AgNPs)
X26-06-ZQ3131 Silver nanoparticle-modified polymer micelles
X26-06-ZQ3132 IgG antibody-functionalized silver nanoparticles (IgG-AgNPs)
X26-06-ZQ3133 Enzyme-functionalized silver nanoparticles (Enzyme-AgNPs)
X26-06-ZQ3134 Silver nanoparticle-modified polyurethane (Ag-PU)
X26-06-ZQ3135 Carbohydrate-functionalized silver nanoparticles
X26-06-ZQ3136 Drug-loaded silver nanoparticles
X26-06-ZQ3137 Silver nanoparticle/chitosan/acetylene black ternary nanocomposites (Ag/CS/AB)
X26-06-ZQ3138 Norfloxacin-functionalized silver nanoparticles
X26-06-ZQ3139 Silver nanoparticle/chitosan/acetylene black ternary nanocomposites (Ag/CS-AB)
X26-06-ZQ3140 Polydopamine/silver nanoparticle co-modified porous titanium
X26-06-ZQ3141 Silk fibroin nanoparticle-coated manganese dioxide (Manganese dioxide@SF NPs)
X26-06-ZQ3142 Flexible substrate zinc oxide-enzyme bio-interfaces (ZnO-Enzyme/Flexible substrate)
X26-06-ZQ3143 Bismuth sulfide/zinc protoporphyrin nanocomposites (Bi2S3/ZnPP)
PRODUCTS
Featured Products
Nucleic Acid Drug Delivery Products
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010) GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011) GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012) GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014) Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015) Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016) Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017) GalNAc-L96-OH (Cat#: X24-11-YM018) GalNAc-L96-TEA (Cat#: X24-11-YM019)
Hots Products
N-Glycan
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036) A2G2 N-Glycan (Cat#: X23-03-YW037) A2G2S2 N-Glycan (Cat#: X23-03-YW038) A2 N-Glycan (Cat#: X23-03-YW039) A2[6]G1 N-Glycan (Cat#: X23-03-YW040) M3 N-Glycan (Cat#: X23-03-YW041) A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
O-Glycan
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178) Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179) Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180) Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181) Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182) T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192) T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193) Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood Group and Lewis Antigen
Blood group A trisaccharide (Cat#: XCO0060Q) Blood group B trisaccharide (Cat#: XCO0068Q) Blood group H disaccharide (Cat#: XCO0074Q) Lewis A trisaccharide (Cat#: XCO0079Q) 3'-Sulfated lewis A (Cat#: XCO0080Q) Lewis B tetrasaccharide (Cat#: XCO0083Q) Lewis X trisaccharide (Cat#: XCO0085Q) Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Human Milk Oligosaccharides (HMOs)
Lacto-N-biose (Cat#: XCO0089Q) 2'-Fucosyllactose (Cat#: XCO0091Q) 3-Fucosyllactose (Cat#: XCO0092Q) Lactodifucotetraose (Cat#: XCO0093Q) Lacto-N-triose I (Cat#: XCO0094Q) 3'-Sialyllactose sodium salt (Cat#: XCO0096Q) 6'-Sialyllactose sodium salt (Cat#: XCO0098Q) 3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Glycosaminoglycans
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478) FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480) TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481) Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482) Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598) Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611) Heparin disaccharide I-A (Cat#: X22-11-ZQ662) Chondroitine sulfate (Cat#: X23-04-XQ1118)
Carbohydrate Conjugates
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008) Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037) Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038) Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039) Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
Glycolipids
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101) GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112) LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118) Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131) Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146) Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162) Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175) nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Cyclodextrin
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119) Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003) Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004) Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005) Succinyl-γ-cyclodextrin (Cat#: X23-11-B006) ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007) β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008) γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Dextran
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273) Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279) FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280) FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283) TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287) FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291) Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377) TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383) Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Important Links

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.